Syneos Health, Inc. (SYNH) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Morrisville, NC, United States. Le PDG actuel est Michelle Keefe.
SYNH a date d'introduction en bourse 2014-11-07, 28,768 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $4.46B.
Syneos Health, Inc. is a global biopharmaceutical outsourcing solutions provider headquartered in Morrisville, North Carolina, serving clients across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. The company operates through two primary segments: Clinical Solutions, which offers comprehensive development services for diagnostics, drugs, biologics, devices, and digital therapeutics across Phase I to IV clinical trials, including regulatory consulting, patient recruitment, clinical monitoring, and trial diversity support; and Commercial Solutions, which provides commercialization services including deployment strategies, communications solutions such as public relations and medical communications, and consulting services to pharmaceutical, biotechnology, and healthcare companies. With a history of innovation in the biopharmaceutical services industry, Syneos Health has established itself as a key partner for companies navigating drug development and market commercialization.
